Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Nature Medicine
|
November 6, 2019
Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer
Pooja Ghatalia, Elizabeth Plimack
European Urology Focus
|
April 23, 2025
A Practical Guide for the Management of Toxicities Associated with Belzutifan
Joy Li, Pooja Ghatalia
Translational Andrology and Urology
|
December 10, 2025
From surgery to systemic therapy: long-term lessons of belzutifan in von Hippel-Lindau disease
Max Schnoll, Pooja Ghatalia
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Integration of Immunotherapy Into the Treatment of Advanced Urothelial Carcinoma
Pooja Ghatalia, Elizabeth R Plimack
European Urology
|
September 5, 2022
Adding a Fourth Modality to Trimodal Therapy for Muscle-invasive Bladder Cancer
Pooja Ghatalia, Elizabeth R Plimack
Nature Reviews. Clinical Oncology
|
September 4, 2023
Harnessing potent therapies with care: enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma
Pooja Ghatalia, Elizabeth R Plimack
Kidney Cancer (Clifton, Va.)
|
October 16, 2018
Systematic Review: ClearCode 34 - A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
Pooja Ghatalia, W Kimryn Rathmell
Expert Opinion on Biological Therapy
|
July 21, 2023
Muscle invasive bladder cancer: where is the field headed?
Pooja Ghatalia, Jasmeet Kaur, Guru Sonpavde
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 17, 2026
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer
Joy Li, Leslie Ballas, Pooja Ghatalia
Critical Reviews in Oncology/Hematology
|
November 25, 2015
Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials
Pooja Ghatalia, Charity J Morgan, Guru Sonpavde
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Nature Medicine
|
November 6, 2019
Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer
Pooja Ghatalia, Elizabeth Plimack
European Urology Focus
|
April 23, 2025
A Practical Guide for the Management of Toxicities Associated with Belzutifan
Joy Li, Pooja Ghatalia
Translational Andrology and Urology
|
December 10, 2025
From surgery to systemic therapy: long-term lessons of belzutifan in von Hippel-Lindau disease
Max Schnoll, Pooja Ghatalia
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Integration of Immunotherapy Into the Treatment of Advanced Urothelial Carcinoma
Pooja Ghatalia, Elizabeth R Plimack
European Urology
|
September 5, 2022
Adding a Fourth Modality to Trimodal Therapy for Muscle-invasive Bladder Cancer
Pooja Ghatalia, Elizabeth R Plimack
Nature Reviews. Clinical Oncology
|
September 4, 2023
Harnessing potent therapies with care: enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma
Pooja Ghatalia, Elizabeth R Plimack
Kidney Cancer (Clifton, Va.)
|
October 16, 2018
Systematic Review: ClearCode 34 - A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
Pooja Ghatalia, W Kimryn Rathmell
Expert Opinion on Biological Therapy
|
July 21, 2023
Muscle invasive bladder cancer: where is the field headed?
Pooja Ghatalia, Jasmeet Kaur, Guru Sonpavde
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 17, 2026
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer
Joy Li, Leslie Ballas, Pooja Ghatalia
Critical Reviews in Oncology/Hematology
|
November 25, 2015
Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials
Pooja Ghatalia, Charity J Morgan, Guru Sonpavde
Page
of 7